Abstract
To undertake a cost-effectiveness analysis of using microarray comparative genomic hybridisation (array-CGH) as a first-line test versus as a second-line test for the diagnosis of causal chromosomal abnormalities in patients referred to a NHS clinical genetics service in the UK with idiopathic learning disability, developmental delay and/or congenital anomalies.
Original language | English |
---|---|
Pages (from-to) | 421-432 |
Number of pages | 12 |
Journal | Applied Health Economics and Health Policy |
Volume | 13 |
Issue number | 4 |
Early online date | 19 Apr 2015 |
DOIs | |
Publication status | Published - Aug 2015 |